SecBot SecBot
EFFECT ·Filed Aug 13, 2026

CRIS

CURIS INC
BEARISH
Impact 6/10
Horizonimmediate Processed3mo ago SEC9999999995-26-002653
IPO/offering going effective
Actionable Insight ▼ Bearish

Expect a priced offering announcement within 1-2 days. The dilutive overhang will pressure the stock until the offering terms (size, price, discount) are disclosed. Traders should watch for the prospectus (424B4) for exact share count and price; any discount to market will accelerate selling. Given the micro-cap status, the offering may be structured as a registered direct or at-the-market (ATM) facility.

DirectionBearish
Confidencehigh
Horizonimmediate

How the stock moved after the report

BEARISH VIEWSTOCK BELOW ENTRY AT T+60
Entry
$1.87
T+0 close · Aug 13, 2026 · via day close
Latest settled
−51.52%
T+60 · $0.9065
Vs SPY
−46.05%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Aug 13 $1.87entry
  2. T+1 · 3mo ago −3.74%α −3.55% · $1.80
  3. T+5 · 3mo ago −13.90%α −11.94% · $1.61
  4. T+20 · 2mo ago −39.57%α −37.83% · $1.13
  5. T+60 · 11d ago −51.52%α −46.05% · $0.9065
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Curis Inc.'s S-1 registration statement (File No. 333-298203) was declared effective by the SEC on August 12, 2026, under the 1933 Act. This allows the company to proceed with a securities offering, which for a micro-cap biotech with a $5M market cap is likely a dilutive follow-on or at-the-market offering. The effectiveness creates immediate dilution overhang for existing common shareholders, as the company can now sell shares to raise capital.

Key Facts

  • SEC declared effective Curis Inc.'s S-1 registration statement (File No. 333-298203) on August 12, 2026.
  • The effectiveness allows Curis to sell securities under the 1933 Act, typically a dilutive follow-on offering for a micro-cap biotech.
  • Curis has a market capitalization of approximately $5M, making any new share issuance materially dilutive.
  • The company is a clinical-stage biotech (SIC 2836) with no disclosed revenue or product sales in the filing.

Financial Impact

Undisclosed amount; the S-1 registration does not specify the size or price of the offering. Given the $5M market cap, even a modest offering (e.g., $1-2M) would be highly dilutive to existing shareholders.

dilutionshare countcash runway

Risk Factors

  • Immediate dilution from new share issuance could depress stock price by 10-30% depending on offering size and discount.
  • No disclosed use of proceeds or business update, the offering may signal cash burn concerns and a need for emergency capital.
  • Micro-cap biotech with $5M market cap faces high delisting risk if Nasdaq minimum bid price or market value requirements are not met.

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
90% bullish (10 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
EFFECT Filing (Primary)9999999995-26-002653
Document: 9999999995-26-002653-index.html9999999995-26-002653
Document: 9999999995-26-002653.txt9999999995-26-002653

Track record

18 reports on CRIS

Performance horizon

6 of 8 bullish or bearish reports moved the stock their way by T+1. Best: +82.45% at T+60 after the May 22, 2026 report. 8 of 8 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G Neutral 4/10 Entry $0.4200 Now $0.4400 +4.76% settles Nov 17
  2. Nov 13, 20263d ago SC 13G/A Neutral 3/10 Entry $0.6000 Now $0.4400 −26.67% settles Nov 17
  3. Nov 13, 20263d ago SC 13G/A Neutral 2/10 Entry $0.5010 Now $0.4400 −12.18% settles Nov 17
  4. Nov 13, 20263d ago S-3 Bearish 7/10 Entry $0.6000 Now $0.4400 +26.67% settles Nov 17
  5. Nov 13, 20263d ago 8-K Neutral 4/10 Entry $0.4450 Now $0.4400 −1.12% settles Nov 17
  6. Nov 12, 20264d ago Press Release Bearish 6/10 Entry $0.4450 to $0.4358 Now $0.4400 +1.12% ▲ +2.07% +0.16% vs SPY
  7. Nov 10, 20266d ago SC 13G/A Neutral 3/10 Entry $0.6530 to $0.5915 Now $0.4400 −32.62% ▼ −9.42% −10.74% vs SPY
  8. Nov 6, 202610d ago 8-K Bearish 7/10 Entry $0.6976 to $0.6530 Now $0.4400 +36.93% ▲ +6.39% +6.03% vs SPY
  9. Nov 2, 202614d ago DEF 14A Neutral 4/10 Entry $0.6610 to $0.7139 Now $0.4400 −33.43% ▲ +8.00% +7.70% vs SPY
  10. Oct 19, 202628d ago 8-K Bearish 6/10 Entry $0.3996 to $0.3920 Now $0.4400 −10.11% ▲ +1.90% +2.43% vs SPY
Showing 10 of 18

US Market Status

Market Closed · Opens in 6h 19m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 13, 2026